Cite
HARVARD Citation
Wilson, J. et al. (2022). The dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A post hoc analysis. Diabetes, obesity & metabolism. 24 (1), pp. 148-153. [Online].